Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine Volume for IANB in Irreversible Pulpitis
NCT02422823Completed
- Start
- Apr 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of articaine in irreversible pulpitis. Primary endpoint: Pain measured by a verbal analog scale. Started Apr 2015; status: completed.
02
Drugs
articaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT02422823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422823.